Funders › CT › The Multiple Myeloma Research Foundation Inc › 2024
Grants paid by The Multiple Myeloma Research Foundation Inc, tax year 2024
EIN 06-1504413 · Norwalk, CT · Form 990, Schedule I · NTEE G50
In tax year 2024, The Multiple Myeloma Research Foundation Inc (EIN 06-1504413) reported 17 grants paid totaling $4,771,050. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2024
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Icahn School of Medicine at Mount Sinai New York, NY | A | $1,900,000 | paid | SITE INVESTMENT GRANT, IMMUNOTHERAPY, MYELOMA ACCELERATOR CHALLENGE GRANT | 202512889349301411 |
| 2024 | Dana Farber Cancer Institute Boston, MA | A | $1,000,000 | paid | SITE INVESTMENT GRANT, PREVENTION | 202512889349301411 |
| 2024 | Beth Israel Deaconess Medical Center Boston, MA | A | $860,550 | paid | SITE INVESTMENT GRANT, IMMUNOTHERAPY | 202512889349301411 |
| 2024 | Emory University Atlanta, GA | A | $563,000 | paid | SITE INVESTMENT GRANT, IMMUNOTHERAPY | 202512889349301411 |
| 2024 | City of Hope Durate, CA | U | $105,000 | paid | SITE INVESTMENT GRANT, FELLOW, IMMUNOTHERAPY | 202512889349301411 |
| 2024 | University of Texas- Southwestern Medical Center Dallas, TX | A | $60,000 | paid | FELLOW | 202512889349301411 |
| 2024 | The Regents of the University of California San Francisco San Francisco, CA | A | $60,000 | paid | IMMUNOTHERAPY | 202512889349301411 |
| 2024 | Ohio State University Research Foundation Columbus, OH | A | $30,000 | paid | FELLOW | 202512889349301411 |
| 2024 | Memorial Sloan-Kettering Cancer Center New York, NY | A | $25,000 | paid | SITE INVESTMENT GRANT | 202512889349301411 |
| 2024 | Hackensack University Medical Center Hackensack, NJ | A | $25,000 | paid | SITE INVESTMENT GRANT | 202512889349301411 |
| 2024 | Barbara Ann Karmanos Cancer Hospital Detroit, MI | A | $25,000 | paid | SITE INVESTMENT GRANT | 202512889349301411 |
| 2024 | Massachusetts General Hospital Boston, MA | A | $25,000 | paid | SITE INVESTMENT GRANT, IMMUNOTHERAPY | 202512889349301411 |
| 2024 | Tennessee Oncology Pllc Nashville, TN | A | $25,000 | paid | SITE INVESTMENT GRANT | 202512889349301411 |
| 2024 | Washington University in St Louis St Louis, MO | A | $25,000 | paid | SITE INVESTMENT GRANT, IMMUNOTHERAPY | 202512889349301411 |
| 2024 | The University of Chicago Chicago, IL | A | $25,000 | paid | SITE INVESTMENT GRANT | 202512889349301411 |
| 2024 | Be the Match Foundation Minneapolis, MN | A | $10,000 | paid | IMMUNOTHERAPY | 202512889349301411 |
| 2024 | Indiana University Bloomington, IN | A | $7,500 | paid | FELLOW | 202512889349301411 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.